Christie Ballantyne, United States of America
TBA TBA
Presenter of 3 Presentations
Therapeutic Approaches - The NLA way
Session Type
Joint symposium
Session Time
14:30 - 15:30
Lecture Time
15:15 - 15:30
[{"name":"Therapeutic Approaches - The NLA way","mode":"playlist","public":true,"info":{"id":1529,"presentation":"Therapeutic Approaches - The NLA way","session":"NLA\/EAS joint session - Dyslipidemia Treatment in Light of the New Guidelines","presenter":"Christie Ballantyne, United States of America","photo":""},"playlist":[{"name":"","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/2\/Christie Ballantyne - EAS20 - 1529 - Therapeutic Approaches - The NLA Way.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/2\/Christie Ballantyne - EAS20 - 1529 - Therapeutic Approaches - The NLA Way.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/2\/E593EACD.jpg","data":[],"tracks":[]}]}]
{"provider":"CTI","provider_live":0,"type":1,"code":"aE22Xi0sn"}
[session]
[presentation]
[presenter]
Position of omega 3 in Guidelines (as second choice after statins)
Session Time
15:30 - 17:00
Lecture Time
16:01 - 16:15
[{"name":"Position of omega 3 in Guidelines (as second choice after statins)","mode":"playlist","public":true,"info":{"id":1513,"presentation":"Position of omega 3 in Guidelines (as second choice after statins)","session":"The role of TG-rich lipoproteins in atherosclerosis","presenter":"Christie Ballantyne, United States of America","photo":""},"playlist":[{"name":"Position of omega 3 in Guidelines (as second choice after statins","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/107\/Christie M. Ballantyne MD EAS20 1513 Position of omega 3 in Guidelines (as second choice after statins.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/107\/Christie M. Ballantyne MD EAS20 1513 Position of omega 3 in Guidelines (as second choice after statins.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/107\/63228A2.jpg","data":[],"tracks":[]}]}]
{"provider":"CTI","provider_live":0,"type":1,"code":"9E22Xi0s6"}
[session]
[presentation]
[presenter]
Panel Discussion with Live Q&A
Session Time
15:30 - 17:00
Lecture Time
16:29 - 16:44
[{"name":"Panel Discussion with Live Q&A","mode":"playlist","public":true,"info":{"id":1536,"presentation":"Panel Discussion with Live Q&A","session":"The role of TG-rich lipoproteins in atherosclerosis","presenter":"Philippe Moulin, France, Jan Boren, Sweden, Ruth Frikke-Schmidt, Denmark, Alberto Zambon, Italy, Christie Ballantyne, United States of America, Dirk M\u00fcller-Wieland, Germany","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/eas20\/persons\/photos\/619.jpg"},"playlist":[{"name":"The role of TG-rich lipoproteins in atherosclerosis","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/107\/The role of TG-rich lipoproteins in atherosclerosis.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/107\/The role of TG-rich lipoproteins in atherosclerosis.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/107\/AA505DC4.jpg","data":[],"tracks":[]}]}]
{"provider":"CTI","provider_live":0,"type":1,"code":"7E22Xi0su"}
[session]
[presentation]
[presenter]
